Panbela Therapeutics, Inc. (PBLA) Financials

PBLA Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 5.2 million 23.3 million
June 30, 2024 9.4 million 20.0 million
March 31, 2024 10.5 million 13.7 million
Dec. 31, 2023 11.8 million 16.5 million

PBLA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -2.1 million ?
June 30, 2024 -981000 ?
March 31, 2024 -9.4 million 103000
Dec. 31, 2023 -3.1 million 124000

PBLA Net Income

No data available :(

PBLA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 142000 3.2 million -
June 30, 2024 59000 3.2 million -
March 31, 2024 262000 3.2 million -
Dec. 31, 2023 2.6 million 4.2 million -

PBLA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 ?
June 30, 2024 ?
March 31, 2024 ?
Dec. 31, 2023 ?

PBLA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 6.1 million 1.1 million -
June 30, 2024 - 7.0 million 1.1 million -
March 31, 2024 - 5.5 million 1.2 million -
Dec. 31, 2023 - 6.1 million 931000 -

PBLA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 - 7.2 million
June 30, 2024 - 8.1 million
March 31, 2024 - 6.7 million
Dec. 31, 2023 - 7.0 million

PBLA

Price: $0.01

52 week price:
0.00
2.50

Earnings Per Share: -34.51 USD

P/E Ratio: -0.01

Exchange: OQB

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 2.4 million

Market Capitalization: 53889

Links: